Buscar
Mostrando ítems 1-10 de 26
Role of polymorphonuclear leukocytes in the pathophysiology of typical hemolytic uremic syndrome
(HINDAWI publishing Corporation, 2007-08)
Thrombotic microangiopathy and acute renal failure are cardinal features of post-diarrheal hemolytic uremic syndrome (HUS). These conditions are related to endothelial and epithelial cell damage induced by Shiga toxin ...
Hemolytic uremic syndrome: pathogenesis and update of interventions
(Future Drugs Ltd., 2009-12)
The typical form of hemolytic uremic syndrome (HUS) is the major complication of Shiga toxin-producing Escherichia coli infections. HUS is a critical health problem in Argentina since it is the main cause of acute renal ...
Activation of the alternative pathway of complement during the acute phase of typical haemolytic uraemic syndrome
(Wiley, 2015-06)
Haemolytic uraemic syndrome (HUS) is characterized by haemolytic anaemia, thrombocytopenia and acute renal failure. We studied the activation state of classical and alternative pathways of complement during the acute phase ...
Microangiopatias trombóticas: púrpura trombocitopênica trombótica e síndrome hemolítico-urêmica
(Sociedade Brasileira de Nefrologia, 2010-09-01)
Thrombotic microangiopathies (TMAs) are pathological conditions characterized by generalized microvascular occlusion by platelet thrombi, thrombocytopenia, and microangiopathic hemolytic anemia. Two typical phenotypes of ...
Relevance of bacteriophage 933W in the development of hemolytic uremic syndrome (HUS)
(Frontiers Research Foundation, 2018-12)
Hemolytic uremic syndrome (HUS), principally caused by Shiga toxins (Stxs), is associated with Shiga toxin-producing Escherichia coli (STEC) infections. We previously reported Stx2 expression by host cells in vitro and in ...
The oxidative stress induced in vivo by Shiga toxin-2 contributes to the pathogenicity of haemolytic uraemic syndrome
(Wiley Blackwell Publishing, Inc, 2013-08)
Typical haemolytic uraemic syndrome (HUS) is caused by Shiga toxin (Stx)- producing Escherichia coli infections and is characterized by thrombotic microangiopathy that leads to haemolytic anaemia, thrombocytopenia and acute ...
Participación de la respuesta inmune en el desarrollo del síndrome urémico hemolítico
(Asociación para el progreso de las Ciencias, 2012-08)
La forma típica o post-diarreica del Síndrome Urémico Hemolítico (SUH) es la complicación más grave de las infecciones por cepas de Escherichia coli productoras de toxina Shiga (STEC). En Argentina el SUH es un problema ...
Intracerebroventricular administration of Shiga toxin type 2 altered the expression levels of neuronal nitric oxide synthase and glial fibrillary acidic protein in rat brains
(Elsevier Science, 2008)
Shiga toxin (Stx) from enterohemorrhagic Escherichia coli (STEC) is the main cause of hemorrhagic colitis which may derive into Hemolytic Uremic Syndrome (HUS) and acute encephalopathy, one of the major risk factors for ...
Diarrhoeagenic Escherichia coli and Escherichia albertii in Brazil: pathotypes and serotypes over a 6-year period of surveillance
(Cambridge Univ Press, 2019-01-01)
Diarrhoeagenic Escherichia coli (DEC) is a leading cause of infectious diarrhoea worldwide. In recent years, Escherichia albertii has also been implicated as a cause of human enteric diseases. This study describes the ...
Actualización en el tratamiento del síndrome urémico hemolítico endémico: Patogénesis y tratamiento de la complicación sistémica más grave de las infecciones por Escherichia coli productor de toxina ShigaUpdate on the treatment of endemic hemolytic uremic syndrome. Pathogenesis and treatment of the most severe systemic complication of infections by Shiga toxin-producing Escherichia coli
(Medicina (Buenos Aires), 2011-08)
La forma típica o post-diarreica del síndrome urémico hemolítico (SUH) es la complicación más grave de las infecciones por cepas de Escherichia coli productoras de toxina Shiga (STEC). En la Argentina el SUH es un problema ...